The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling
about
Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and LociThe role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancerCurrent aspects of vitiligo geneticsCross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal CancerGenome-wide association analyses identify 13 new susceptibility loci for generalized vitiligoThe ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study.Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.Association Study of rs3184504 C>T Polymorphism in Patients With Coronary Artery Disease.LNK (SH2B3): paradoxical effects in ovarian cancer.ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish populationThe contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease.Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammationSH2B3 (LNK) as a novel link of immune signaling, inflammation, and hypertension in Dahl salt-sensitive hypertensive rats.The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation.LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.Association of cardiovascular and metabolic disease genes with psoriasisIncreased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasmsLnk is an important modulator of insulin-like growth factor-1/Akt/peroxisome proliferator-activated receptor-gamma axis during adipogenesis of mesenchymal stem cells.Genetic predisposition to higher blood pressure increases coronary artery disease risk.Specific disruption of Lnk in murine endothelial progenitor cells promotes dermal wound healing via enhanced vasculogenesis, activation of myofibroblasts, and suppression of inflammatory cell recruitment.Refractory celiac disease: from bench to bedside.Circulating microRNAs in patients with polycystic ovary syndrome.Candidate genes for hypertension: insights from the Dahl S rat.Linking inflammation and hypertension via LNK/SH2B3.The function of SH2B3 (LNK) in the kidney.Recent advances of adapter proteins in the regulation of heart diseases.Role of the Immune System in Hypertension.Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.Genetic variants regulating immune cell levels in health and disease.Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.Transcriptomic alterations during ageing reflect the shift from cancer to degenerative diseases in the elderly.Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients.MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.Identification of nine new susceptibility loci for endometrial cancer
P2860
Q26766384-A38CFB99-928F-4554-8161-CB9777AC6DA4Q26770682-272BC3F6-104E-4471-A641-7437A0A4C68CQ27003993-646CB19B-D55A-4FC5-BB51-B8EA582A6414Q28396029-A9DDD04A-A48F-43FB-8C55-9A6D237F4266Q28924362-8A0EB5FE-867F-42F3-BDE2-3E953D3C3CF0Q29417153-4AA109AE-2182-4826-B1B1-EBF509E21AA0Q30301275-03D2DAA0-6847-432E-8431-8F119BE26792Q33691329-74FEB9A3-F5E2-4032-9C62-99AD94BF84C7Q34221086-5D21B368-B979-4113-ACAA-BB7156D270AEQ34302585-B3A0BD53-DE1E-49F5-9485-5DC4C69829CDQ34391155-D90F830F-47EF-4CAA-957C-67986B0002D2Q35130067-F624808F-60C1-4EE3-871F-9A7220A19909Q35183974-1EFFC0CA-0631-47D4-8D68-7352A0C76DE9Q35365299-38B586C8-B8B6-4666-B48D-D1A39DB0494EQ35540524-E1388873-5061-4764-9108-81F5225B5D64Q35547023-2153DB97-CBEA-409F-89F5-E988E4FC04E2Q35987858-AE92C01F-9AD5-4A41-85F5-7F28D9595E46Q36605296-6BA1045F-32AD-4157-ACBE-CC888230551FQ36842989-F7250DA5-9745-4EB5-AEC2-29F51BAC5FD5Q36981341-1C8874BB-29E8-4305-893B-C1DB1129940CQ37168138-E572CCBE-307A-4221-ADD5-7D09A1951C68Q37239762-760783F4-A27C-4440-9DB9-D19D5FEDB0D8Q37373465-C903A226-A4BB-4055-BB39-62855FA12FABQ37374803-F42DB0E0-A833-4918-ADCF-A6B2FC250FD3Q38027424-024ADDA8-57E9-4EE5-B4F1-D62C7432A122Q38303833-E2F1F7AC-A6BC-4B00-B2E1-A30E73108AA7Q38422660-380CCFA2-1EC2-4715-AE83-2866AF5BEC6EQ38599672-587DB083-2D5E-487B-913A-59EE17C066DFQ38903897-58F5DC54-0B25-434C-9EB1-3A23A194A5D9Q38953404-1E1A377A-3D56-45C5-BD51-61EA80146889Q39342382-9B70F6DE-6ADB-44D6-ADE1-FBB3664803BDQ40044046-BDFF2834-9B40-47E5-9CA0-2673E9D90D10Q41229283-D90BAF45-E871-4EBB-997F-B039395D0840Q41677325-2F7E7C1C-C60F-468D-B289-C0DE89922DFDQ47864520-DDC5DBED-6686-424A-9FEF-3BF7DEB6EED7Q48043053-D7E9ADD9-6461-494C-981B-6D94B607B129Q48134030-BC0D865C-C644-418D-82FC-918B0BDAF8EFQ50044432-3537B943-4887-4930-B29F-DDC0E8EC35EBQ57170142-995D16AC-B281-4F55-AF05-A30BB560A95F
P2860
The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@ast
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@en
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@nl
type
label
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@ast
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@en
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@nl
prefLabel
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@ast
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@en
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@nl
P3181
P1476
The adaptor Lnk (SH2B3): an em ...... une and inflammatory signaling
@en
P2093
Béatrice Charreau
Julie Devallière
P304
P3181
P356
10.1016/J.BCP.2011.06.023
P407
P577
2011-11-15T00:00:00Z